按此在新窗口浏览图片

About Wanbang
  As one of the leading biological pharmaceutical enterprises and largest manufacturer of insulin in China, our insulin series products take 48% of the domestic market.

  We engage in manufacturing and marketing the diabetic care products, cardiovascular drugs, provide service to people with diabetes since 1981.

  Our sales force, consisted by 300 professional sales person, has business relationship with 2600 domestic hospitals and is developing overseas market.

Our Mission
  We devote ourselves to defeating diabetes.

Our Objective
  We are aiming at becoming an influencing manufacturer of diabetic drugs in the world.

Research & Development
  According to Wanbang’s strategy in developing new drugs - focus on diabetic medicines, extend in hyperlipidemia and hypertension, we emphasize on enriching the diabetic product pipelines and set a professional image in both diabetic medication and service field.